Archives

November 8, 2018
The Opioid Crisis: Our Defining Moment

...out there suffering from the impacts of opioids, at the individual, family, and community levels. For every one person who dies from opioid overdose, 50 more individuals have an opioid...

READ MORE
February 9, 2020
FDA Approves Diazepam Nasal Spray and Fast Tracks New Drug for Spinal Cord Injury

...placebo-controlled, repeat dose study in chronic cervical spinal cord injury. Up to 24 patients will randomly receive AXER-204 or placebo, with dose level and dose frequency dependent on outcomes from...

READ MORE
April 17, 2023
Build Your Army: Maintaining Cybersecurity Amid the IT Talent Gap

...Research also shows that cybersecurity demand is twice as great as supply. The problem is compounded for workers’ comp organizations, which are highly valuable cyber targets due to the large...

READ MORE
April 15, 2021
FDA and CDC Recommend Resuming Use of Johnson & Johnson COVID-19 Vaccine

...women is cerebral venous sinus thrombosis (CVST), which was seen in combination with low levels of blood platelets (thrombocytopenia). All six cases occurred in women between the ages of 18...

READ MORE
September 24, 2021
FDA Approves Pfizer COVID-19 Vaccine, Booster Shots on the Way

In late August, the FDA officially approved the Pfizer-BioNTech COVID-19 vaccine, which will officially be marketed as Comirnaty. This is the first FDA-approved vaccine for the prevention of COVID-19 and...

READ MORE
January 18, 2024
Certain Vancomycin, Phenylephrine, and Fentanyl IV Bags Recalled Due to Superpotency

Leiters Health is voluntarily recalling 33 lots of IV vancomycin, phenylephrine, and fentanyl products at the user level due to superpotency because the bags may contain twice the labeled amount...

READ MORE
May 19, 2023
Teva Pharmaceuticals Recalls Specific Lots of Fentanyl Buccal Tablets CII

Teva Pharmaceuticals has voluntarily recalled specific lots of various strengths of fentanyl buccal tablets CII at the consumer level due to a labeling error. This recall has been initiated because...

READ MORE
September 4, 2019
DEA to Improve Access to Marijuana Research

...384 to 542, approximately 40%. Historically, research institutions have faced much difficulty completing the intensive, time-consuming application process to study marijuana that required cooperation with the DEA, the National Institute on Drug...

READ MORE
April 9, 2018
Dr. Silvia Sacalis Discusses Value-Based Care with WorkCompWire

Healthesystems’ VP of Clinical Services, Silvia Sacalis, PharmD, BS, recently appeared in the Leaders Speak series featured in WorkCompWire, an online news service focused on workers’ comp. Her article discusses how...

READ MORE
October 17, 2022
Things Change: The Growing Diversity of Pharmacy Cost Drivers

...utilization has decreased, which is not unexpected. NSAIDs account for 18% of prescription workers’ comp drug payments.3 Commonly used orals NSAIDs include:* Aspirin Ibuprofen (Motrin®, Advil®) Naproxen (Aleve®) Meloxicam (Mobic®)...

READ MORE
1 34 35 36 37 38 42
lockenvelopephone-handsetmagnifiermenucross-circle